Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance-Reference-Cited by-同舟云学术

Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance

Published:2023-02-06 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Peng Guang¹²³,Wang Chao¹⁴,Wang Hongru⁵,Qu Min⁶,Dong Keqin⁷,Yu Yongwei⁸,Jiang Yuquan²⁹,Gan Sishun⁵,Gao Xu⁶

Affiliation:

1. Department of Urinary Surgery, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China

2. Department of Orthopedic, Joint Logistic Support Force No. 925 Hospital of PLA, Guiyang, China

3. Department of Burns and Plastic Surgery, General Hospital of Southern Theater Command of PLA, Guangzhou, China

4. Shanghai Health Commission Key Lab of Artificial Intelligence (AI)-Based Management of Inflammation and Chronic Diseases, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China

5. Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, China

6. Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China

7. Department of Urology, Chinese PLA general hospital of central theater command, Wuhan, China

8. Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China

9. Central Lab of Joint Logistic Support Force No. 925 Hospital of PLA, Guiyang, China

Funder

National Natural Science Foundation of China

Shanghai Natural Science Foundation

Pudong New Area Science and technology development fund special fund for people’s livelihood Research

The Top-level Clinical Discipline Project of Shanghai Pudong

Construction of clinical peak discipline of Shanghai Pudong New Area Health Committee

Shanghai Sailing Program

Science and Technology Foundation of the Health Commission of Guizhou province

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2173422

Reference39 articles.

1. Studies on prostatic cancer

2. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

3. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

4. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

5. Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

2. The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management;Cellular & Molecular Biology Letters;2024-05-14

3. Tumor-Associated Macrophages and Their Role in Cancer Progression and Treatment Strategies;Interdisciplinary Cancer Research;2024

4. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway;Journal of Translational Medicine;2023-12-06

5. The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors;International Journal of Biological Sciences;2023